Overview: Vertex leads the list with a $120B market cap, $12.95B–$13.1B revenue guidance, and strong growth from ALYFTREK and CASGEVY, reinforcing its biotech d ...

Explore 25 Futuristic Technologies You May Live To See, poised to transform health, energy, and daily life. Don't miss these ...

Clayface movie 2026 uses the DC villain’s origin to dramatize CRISPR gene therapy’s central unsolved problem: off-target ...

For many people, managing a disease means chronic therapy. Scribe Therapeutics has a different vision: genetic medicines that offer durable effects for the masses. With its lead program on a path to ...

Agreement marks the first application of Fulcrum® technology in insects, supporting proactive & effective pest controlST. LOUIS, Mo. and DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Pairwise, a ...

CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead asset and multiple upcoming ...

Soilcea has started commercial shipments of its CRISPR-developed CarriCea T1 citrus rootstock following approval.

CRISPR Therapeutics (NasdaqGM:CRSP) has come under pressure after a six day losing streak that cut the stock by about 18%, ...

How can gene editing be used to improve plant health benefits? This is what a recent study published in Frontiers in Plant Science hopes to address as a te | Nature ...

As CRISPR research advances, scientists continue to face challenges in delivery efficiency, model development, and workflow integration. Creative Biolabs addresses these bottlenecks with comprehensive ...